Clinical Course and Outcome of Autoimmune Hepatitis/Primary Sclerosing Cholangitis Overlap Syndrome

Floreani, Annarosa; Rizzotto, Erik Rosa; Ferrara, Francesco; Carderi, Isabella; Caroli, Diego; Blasone, Luigi; Baldo, Vincenzo
July 2005
American Journal of Gastroenterology;Jul2005, Vol. 100 Issue 7, p1516
Academic Journal
Autoimmune hepatitis/primary sclerosing cholangitis (AIH/PSC) overlap syndrome is a relatively uncommon variant of PSC. AIM : To evaluate the natural history of AIH/PSC overlap syndrome compared to a group of “classical” PSC. METHODS : Forty-one consecutive PSC patients, with a regular follow-up of at least 2 years, were prospectively included in the study. Among these, 7 fulfilled the criteria for AIH/PSC overlap syndrome. RESULTS : The AIH/PSC overlap group significantly differed from the “classical” PSC group in the following parameters: mean age at presentation (21.4 ± 5.0 vs 32.3 ± 10 years, p < 0.01), AST 191.0 ± 14.8 vs 48.9 ± 34.5 U/L, p < 0.005), ALT (357.0 ± 26.5 vs 83.7 ± 60.7 U/L, p < 0.005) and serum IgG (25.6 ± 4.7 vs 12.9 ± 6.0 mg/dl, p < 0.0001). The mean follow-up was similar in the 2 groups (93.3 ± 65.9 vs 98.1 ± 65.9 months respectively). Treatment included immunosuppression + ursodeoxycholic acid (UDCA) in the AIH/PSC overlap patients, and UDCA in the “classical” PSC group. Deaths were recorded only in the classical PSC group. The median survival in the latter group was 207 months (95% C.I. 87.6-326.4). The major events during the follow-up included: OLTx (1/7 vs 6/34), and neoplasms (only in the group of “classical” PSC). The new Mayo score prognostic index only increased significantly during follow-up in the “classical” PSC group (r2 0.8117, p < 0.01) CONCLUSION : Patients with AIH/PSC overlap syndrome seem to benefit from immunosuppression + UDCA therapy, survival is apparently better than in “classical” PSC condition. (Am J Gastroenterol 2005;100:1–7)


Related Articles

  • Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited. Sinclair, David; Smith, Helen; Woodhead, Pamela // Annals of Clinical Biochemistry;Mar2004, Vol. 41 Issue 2, p119 

    Background: There are reports in the literature describing artefactually raised phosphate concentrations in serum samples of patients with myeloma. However, IgA paraproteins have been reported only rarely as a potential cause. Methods: Following the detection of a grossly elevated phosphate...

  • An investigation of vibration-induced protein desorption mechanism using a micromachined membrane and PZT plate. Po Yeh; Yevgeniya Le; Jayachandran Kizhakkedathu; Mu Chiao // Biomedical Microdevices;Oct2008, Vol. 10 Issue 5, p701 

    Abstract  A micromachined vibrating membrane is used to remove adsorbed proteins on a surface. A lead zirconate titanate (PZT) composite (3 × 1 × 0.5 mm) is attached to a silicon membrane (2,000 × 500 × 3 μm)...

  • Macroprolactin; high molecular mass forms of circulating prolactin. Fahie-Wilson, M N; John, R; Ellis, A R // Annals of Clinical Biochemistry;May2005, Vol. 42 Issue 3, p175 

    Two high molecular mass forms of prolactin (PRL) in serum have been identified by gel filtration chromatography (GFC): macroprolactin (big–big PRL, > 100 kDa) and big PRL (40–60 kDa). Macroprolactin has a variable composition and structure, but is most frequently a complex of PRL...

  • The Serum Endothelın-1 Level in Steatosıs and NASH, and Its Relatıon wıth Severıty of Lıver Fıbrosıs. Seren Ozenirler; Sehri Elbeg; Gulen Akyol // Digestive Diseases & Sciences;Oct2007, Vol. 52 Issue 10, p2622 

    Abstract  Endothelin-1 (ET-1) is known to play an important role in hepatic fibrosis. ET-1 is also a mediator that is elevated in conditions such as insulin resistance, hyperglycemia, oxidative stress, and endothelial cell dysfunction. In this study, we investigated whether ET-1...

  • Plasma exchange with a rotating filter. Kaplan, Andre A.; Halley, Susan E. // Kidney International;Jul1990, Vol. 38 Issue 1, p160 

    We have modified a rotating filter system to provide therapeutic plasma exchange. Seventeen patients underwent 188 treatments. Blood flows to the filter ranged from 75 to 100 ml/min: mean filtration fraction was 64 ± 1% (± SE, N = 188). Mean plasma removal rate per treatment was 40.2 ±...

  • Suppression of Urushiol-Induced Delayed-Type Hypersensitivity Responses in Mice with Serum IgG Immunoglobulin form Human Hyposensitized Donors. Stampf, Jean-Luc; Castagnoli, Neal; Epstein, William; Baldwin, Robert W.; Byers, Vera // Journal of Investigative Dermatology;Sep90, Vol. 95 Issue 3, p363 

    Serum IgG immunoglobulin fractions from human subjects hyposensitized to poison ivy/oak by oral administration of urushiol suppressed the induction of delayed-type hypersensitivity (DTH) responses in mice to this hapten. This suppressive activity was hapten specific because it did not modify DTH...

  • PRODUCTION OF EPIDERMAL ACANTHOLYSIS IN NORMAL HUMAN SKIN IN VITRO BY THE IgG FRACTION FROM PEMPHIGUS SERUM. Schiltz, John R.; Michel, Beno // Journal of Investigative Dermatology;Aug76, Vol. 67 Issue 2, p254 

    Normal human skin was maintained in organ cultures for several days in Ham's F-10 medium with good preservation of the epidermal cells. When the partially purified IgG fraction from the pooled sera of patients with pemphigus vulgaris or pemphigus foliaceous was added to this culture system,...

  • Recurrence of mesangial deposition of IgA after renal transplantation. Berger, Jean; Yaneva, Halina; Nabarra, Bernadette; Barbanel, Claude // Kidney International;Jan1975, Vol. 7 Issue 1, p232 

    The article presents a study on the recurrence of mesangial deposition of IgA after renal transplantation. Mesangial IgA does not contain secretory piece, and it is usually accompanied by some IgG. In most patients, with mesangial deposition of IgA, the serum concentration of IgA is high, but in...

  • Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in Vitiligo. Harning, Ronald; Jian Cui; Bystryn, Jean-Claude // Journal of Investigative Dermatology;Dec91, Vol. 97 Issue 6, p1078 

    Patients with vitiligo often have antibodies to pigment cells. To examine whether is relation between the presence of such antibodies and disease activity, sera of 24 patients with vitiligo (10 with active and 14 with inactive disease) and 19 normal individual were tested for antibodies to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics